SABA Alone no Longer Recommended for Asthma Management
The Global Initiative for Asthma (GINA) critically revises evidence on asthma management yearly and provides a structured set of recommendations. The 2020 GINA Report maintains a major change in the management recommendations, which were introduced in 2019, in relation to pharmacological treatment. GINA no longer recommends treatment of asthma in adults and adolescents with short-acting beta-2 agonists alone.
Modern Medicine – Issue 5 2021
